Unraveling the Genetic and Physiological Basis of Obesity: The Discovery of Leptin
The Early History of Obesity Research
In the 1960s, Dr. Douglas Coleman at the Jackson Laboratory began studying single-gene mouse mutations like ob/ob and db/db that caused severe early onset obesity. Through elegant parabiosis experiments joining the circulations of these mutant mice to normal mice, Dr. Coleman provided some of the earliest evidence that ob/ob mice lacked an unknown circulating satiety factor, while db/db mice lacked the receptor for this factor.
This discovery pointed to a hormone-receptor model system controlling appetite and weight gain, with the ob/ob mice missing the actual hormone and db/db mice missing the corresponding receptor. It would take decades more work to identify the precise molecular players involved.
The Hunt for Adipose Tissue Signals
In parallel, by the 1970s researchers like Dr. Rudy Leibel became interested in signals secreted by adipose tissue itself that might influence appetite control and weight regulation. But at the time, adipose tissue was viewed merely as a passive storage depot for lipids, not an active endocrine organ.
To pursue this area, Dr. Leibel connected in the 1970s with Dr. Jules Hirsch at Rockefeller University, a pioneer in adipocyte biology. The Leibel and Hirsch labs began experiments in rats to explore whether adipose tissue released unknown hormones affecting appetite as the tissue mass expanded.
Mapping the Genetic Loci for Obesity
By the 1980s, Dr. Leibel collaborated with Dr. Jeffrey Friedman to try to identify the exact chromosomal locations of the ob and db genes by making genetic linkage maps in mice. This involved laborious pre-PCR techniques like Southern blotting to track inheritance of obesity traits across generations of mouse crosses.
After making increasingly higher resolution maps of the ob and db gene loci throughout the ’80s, they were finally poised to pinpoint the precise molecular culprits behind the single-gene obesity mutations.
The Eureka Moment: Cloning Leptin
In 1994, after many failed attempts across over a decade, Dr. Leibel and Dr. Friedman successfully used their ultradense gene maps to molecularly clone the ob gene. They discovered it encoded a new hormone secreted by adipose tissue, which they named “leptin” from the Greek root for “thin.”
The discovery of leptin provided the first convincing evidence for Coleman’s prediction of a circulating satiety factor originating from adipose tissue. Leptin crosses the blood brain barrier to act on receptors in the hypothalamus, suppressing appetite.
In parallel work, Dr. Leibel and Dr. Friedman also succeeded in cloning the db gene and identified mutations in the receptor for leptin, confirming the predicted hormone-receptor mechanism regulating food intake and body weight.
Translating Rodent Science to Humans
The discovery of leptin and leptin receptors launched a flood of research into the physiology of leptin signaling and the pathophysiology of leptin resistance. It helped establish the existence of an endocrine feedback loop between adipose tissue size and hypothalamic appetite control.
However, while rare leptin or leptin receptor mutations cause severe early obesity in humans, the more common situation is leptin resistance, where circuits downstream of leptin signaling become insensitive. This contributes to more complex weight gain processes.
Thus more work remains to translate insights on leptin biology from mouse models into viable treatment approaches targeting obesity and diabetes in humans.
Key Lessons
The scientific journey to identify leptin demonstrates the critical importance of:
- Curiosity-driven basic research
- Animal models in establishing disease mechanisms
- Directly testing hypotheses using elegant experiments like parabiosis
- Passionate collaboration between scientists over many years
- Persistence despite many experimental failures
With progress now accelerated by genomics technologies, the discovery of leptin also laid the foundation to better understand the complex interplay of genetic and environmental factors predisposing humans to obesity in the modern world.
